Emon Elboudwarej is currently the Associate Director of Translational Research at Tempus AI, bringing extensive expertise in bioinformatics, proteomics, epidemiology, and biostatistics with over 15 years of post-graduate experience. Previously, Emon served as a lead oncology bioinformatician and manager at Gilead Sciences, focusing on biomarker research for late-phase clinical studies and exploring the immune landscape in rheumatoid arthritis. Emon also contributed to COVID-19 research, resulting in the first publication on the efficacy of Remdesivir. Emon completed a PhD in Epidemiology, with graduate research at UC Berkeley encompassing various autoimmune disorders.
This person is not in any teams
This person is not in any offices